Patent · US Active

Prevention and treatment of osteoarthritis

US8263546B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 19, 2009
Grant dateSep 11, 2012
Priority date
Expiry dateMay 15, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/105
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Subjects lacking Nfat1 display osteoarthritis in weight-bearing joints. Osteoarthritic changes associated with Nfat1 deficiency are characterized by articular cartilage degradation, articular chondrocyte proliferation/clustering, progressive articular surface destruction, periarticular chondro-osteophyte formation, and exposure of thickened subchondral bone. Methods of treating osteoarthritis, methods of diagnosis and early prediction of the onset of osteoarthritis, and methods for screening drug candidates that may be useful for treatment of osteoarthritis are presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.